ViaCyte to Participate in 2022 Advanced Technologies & Treatments for Diabetes Conference
Dr. Manasi Jaiman, newly appointed Chief Medical Officer, to discuss patient-reported outcomes associated with cell therapy in type 1 diabetes.
Source: pressreleasepoint.com